BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1834179)

  • 1. Inflammatory changes in facioscapulohumeral muscular dystrophy.
    Molnár M; Diószeghy P; Mechler F
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(2):105-8. PubMed ID: 1834179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle CK-B activity in neurogenic muscular atrophies.
    Vretou-Jockers E; Vassilopoulos D
    J Neurol; 1989 Jul; 236(5):284-7. PubMed ID: 2760646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infantile facioscapulohumeral muscular dystrophy: new observations.
    Bailey RO; Marzulo DC; Hans MB
    Acta Neurol Scand; 1986 Jul; 74(1):51-8. PubMed ID: 3766116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle adenylic acid deaminase activity. Selective decrease in early-onset Duchenne muscular dystrophy.
    Kar NC; Pearson CM
    Neurology; 1973 May; 23(5):478-82. PubMed ID: 4735464
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of hydrocortisone on the serum creatine kinase activity of muscles diseases.
    Cxyzewski K
    J Neurol; 1977 Nov; 216(4):283-7. PubMed ID: 72811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The manifesting carrier in Duchenne muscular dystrophy.
    Moser H; Emery AE
    Clin Genet; 1974; 5(4):271-84. PubMed ID: 4854942
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible neurogenic factor in muscular dystrophy: its similarity to denervation atrophy.
    Dastur DK; Razzak ZA
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):399-410. PubMed ID: 4714102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent contributions to the diagnosis of muscle disease.
    Zacks SI
    Hum Pathol; 1970 Sep; 1(3):465-98. PubMed ID: 4942055
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of fibre size, fibre type constitution and spatial fibre type distribution in normal human muscle and in muscle from cases of spinal muscular atrophy and from other neuromuscular disorders.
    Johnson MA; Sideri G; Weightman D; Appleton D
    J Neurol Sci; 1973 Dec; 20(4):345-61. PubMed ID: 4272515
    [No Abstract]   [Full Text] [Related]  

  • 10. Creatine kinase isoenzymes in neuromuscular diseases.
    Somer H; Dubowitz V; Donner M
    J Neurol Sci; 1976 Oct; 29(2-4):129-36. PubMed ID: 978205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A temporal study of enzymes, isozymes, and histochemical changes in Duchenne's dystrophy and neurogenic atrophy.
    Hooshmand H
    Neurology; 1970 Apr; 20(4):409-10. PubMed ID: 5535061
    [No Abstract]   [Full Text] [Related]  

  • 12. Morphometric approaches to perifascicular atrophy in muscle biopsy: do they help to diagnose polymyositis?
    Paljärvi L; Snäll EV
    Neuropathol Appl Neurobiol; 1984; 10(5):333-41. PubMed ID: 6521843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary quadriceps myopathy.
    Espir ML; Matthews WB
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):1041-5. PubMed ID: 4772719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of hemodialysis on the creatine kinase activity in inflammatory muscular diseases].
    Czyzewski K; Kominek-Zalewska M
    Neurol Neurochir Pol; 1979; 13(5):481-5. PubMed ID: 522933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution on the study of pseudohypertrophic muscular dystrophies. I. Benign pseudohypertrophic muscular dystrophy].
    Radu H; Stenzel K
    Dtsch Z Nervenheilkd; 1969; 196(2):92-115. PubMed ID: 5800957
    [No Abstract]   [Full Text] [Related]  

  • 16. Additional biochemical criteria in the differential diagnosis of myositis.
    Zimmermann CW; Langohr HD; Wiethölter H; Peiffer J
    J Neurol; 1987 Dec; 235(2):109-15. PubMed ID: 3430187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inclusion-body myositis: a familial report of 3 cases].
    Miró i Andreu O; Fernández-Solá J; Pedrol Clotet E; Coll-Vinent B; Casademont Pou J; Grau Junyent JM; Urbano-Márquez A
    Rev Clin Esp; 1994 Nov; 194(11):974-7. PubMed ID: 7846355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Muscle LDH isoenzymes in neuromuscular diseases and in carriers of recessive X-linked muscular dystrophy (duchenne)].
    Kowalewski S; Rotthauwe HW
    Z Kinderheilkd; 1972; 113(1):55-70. PubMed ID: 5056500
    [No Abstract]   [Full Text] [Related]  

  • 19. Histochemically demonstrable fibre abnormalities in normal skeletal muscle and in muscle from carriers of Duchenne muscular dystrophy.
    Morris CJ; Raybould JA
    J Neurol Neurosurg Psychiatry; 1971 Jun; 34(3):348-52. PubMed ID: 4328368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory changes in affected muscles of facioscapulohumeral dystrophy.
    Honda H; Mano Y; Takahashi A
    J Neurol; 1987 Aug; 234(6):408-11. PubMed ID: 3655843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.